ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,755, issued on Aug. 19, was assigned to Biond Biologics Ltd. (Misgav, Israel).
"Methods of use for anti-ILT2 antibodies" was invented by Ilana Mandel (Karmiel, Israel), Tsuri Peretz (Kiryat Tivon, Israel), Dana Haves Ziv (Karmiel, Israel), Ilana Goldshtein (Misgav, Israel), Dror Alishekevitz (Kiryat Tivon, Israel), Anna Fridman-Dror (Kibbutz Dalia, Israel), Motti Hakim (Kibbutz Gazit, Israel), Avidor Shulman (Rakefet, Israel), Yair Sapir (Manof, Israel) and Tehila Ben-Moshe (Tel Aviv, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides monoclonal antibodies, or antigen-binding portions thereof, against ILT2, as well ...